Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis

Eitemau Tebyg

• Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
  gan: Nemiche, O, et al.
  Cyhoeddwyd: (2011)
• Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
  gan: Alexeeva, E, et al.
  Cyhoeddwyd: (2011)
• Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
  gan: Horneff, Gerd, et al.
  Cyhoeddwyd: (2017)
• Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
  gan: De Benedetti, F, et al.
  Cyhoeddwyd: (2011)
• 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
  gan: Yokota, S, et al.
  Cyhoeddwyd: (2008)